Allele | N |
NetMHCIIpan
|
TEPITOPE
|
NN-W-P1
|
NN-W
|
NN-xPFR
|
---|
DRB1*0101 | 37 | 0.873 | 0.883 |
0.899
| 0.882 | 0.863 |
DRB1*0301 | 26 | 0.882 | 0.837 | 0.862 |
0.906
| 0.788 |
DRB1*0401 | 209 | 0.865 |
0.876
|
0.865
| 0.843 | 0.848 |
DRB1*0404 | 46 |
0.817
| 0.790 |
0.776
| 0.772 | 0.770 |
DRB1*0405 | 35 | 0.848 | 0.809 |
0.892
| 0.866 | 0.878 |
DRB1*0701 | 36 | 0.687 | 0.711 |
0.761
| 0.754 | 0.757 |
DRB1*0802 | 1 | 0.982 | 0.914 |
0.984
| 0.979 | 0.959 |
DRB1*0901 | 4 | 0.865 | Â | 0.867 | 0.864 |
0.878
|
DRB1*1101 | 27 | 0.873 | 0.863 |
0.894
| 0.876 | 0.881 |
DRB1*1302 | 21 | 0.605 |
0.761
|
0.702
| 0.687 | 0.681 |
DRB1*1501 | 12 | 0.770 | 0.729 | 0.767 | 0.766 |
0.776
|
DRB3*0101 | 2 |
0.957
| Â | 0.680 |
0.730
| 0.681 |
DRB4*0101 | 4 | 0.471 | Â |
0.540
| 0.492 | 0.496 |
DRB5*0101 | 15 | 0.840 | 0.853 |
0.877
| 0.819 | 0.851 |
Ave
| Â | 0.810 | Â | 0.812 | 0.804 | 0.794 |
Ave*
| Â | 0.830 | Â | 0.842 | 0.824 | 0.824 |
Ave**
| Â | 0.822 | 0.821 | 0.844 | 0.834 | 0.824 |
- The benchmark data set consists of 475 HLA-DR restricted ligands downloaded from the SYFPEITHI database of MHC ligands covering 14 HLA-DR alleles. The predictive performance was estimated in terms of the AUC as described in the text. Ave is the average per-allele performance over all 14 alleles. Ave* is the average predictive performance over all 475 ligand/HLA-DR pairs. Ave** is the average per allele performance over the 11 alleles covered by the TEPITOPE method. NetMHCIIpan is the HLA-DR pan-specific method described by Nielsen et al. [23]. TEPITOPE refers to the method developed by Sturniolo et al [17]. NN-W-P1 is the NN-based method including data redundancy step-size rescaling and PSSM-P1 amino acid encoding. NN-W is the NN-based method including data redundancy step-size rescaling. NN-xPFR is the NN-W-P1 method excluding peptide flanking residue encoding. For each allele, the best performing NN method is highlighted in bold and the best performing of all methods is underlined.